nodes	percent_of_prediction	percent_of_DWPC	metapath
Cladribine—ABCG2—epilepsy syndrome	0.332	1	CbGaD
Cladribine—PNP—tongue—epilepsy syndrome	0.00684	0.0625	CbGeAlD
Cladribine—RRM2B—ganglion—epilepsy syndrome	0.00642	0.0587	CbGeAlD
Cladribine—NR5A1—hindbrain—epilepsy syndrome	0.00446	0.0408	CbGeAlD
Cladribine—Abacavir—ADK—epilepsy syndrome	0.00379	0.482	CrCbGaD
Cladribine—POLE4—head—epilepsy syndrome	0.003	0.0275	CbGeAlD
Cladribine—POLE4—nervous system—epilepsy syndrome	0.00285	0.026	CbGeAlD
Cladribine—POLE4—central nervous system—epilepsy syndrome	0.00274	0.0251	CbGeAlD
Cladribine—RRM2B—forebrain—epilepsy syndrome	0.00269	0.0246	CbGeAlD
Cladribine—NR5A1—brainstem—epilepsy syndrome	0.00256	0.0234	CbGeAlD
Cladribine—POLE3—forebrain—epilepsy syndrome	0.00255	0.0233	CbGeAlD
Cladribine—RRM2B—telencephalon—epilepsy syndrome	0.00248	0.0226	CbGeAlD
Cladribine—POLE3—telencephalon—epilepsy syndrome	0.00234	0.0214	CbGeAlD
Cladribine—POLE4—brain—epilepsy syndrome	0.00218	0.0199	CbGeAlD
Cladribine—SLC22A1—ganglion—epilepsy syndrome	0.0021	0.0192	CbGeAlD
Cladribine—RRM2B—medulla oblongata—epilepsy syndrome	0.00195	0.0178	CbGeAlD
Cladribine—POLE3—medulla oblongata—epilepsy syndrome	0.00184	0.0168	CbGeAlD
Cladribine—RRM2B—midbrain—epilepsy syndrome	0.00178	0.0163	CbGeAlD
Cladribine—RRM2B—spinal cord—epilepsy syndrome	0.00174	0.0159	CbGeAlD
Cladribine—POLE3—midbrain—epilepsy syndrome	0.00168	0.0154	CbGeAlD
Cladribine—PNP—head—epilepsy syndrome	0.00166	0.0152	CbGeAlD
Cladribine—POLE3—spinal cord—epilepsy syndrome	0.00164	0.015	CbGeAlD
Cladribine—PNP—nervous system—epilepsy syndrome	0.00158	0.0144	CbGeAlD
Cladribine—RRM2B—head—epilepsy syndrome	0.00154	0.0141	CbGeAlD
Cladribine—PNP—central nervous system—epilepsy syndrome	0.00152	0.0139	CbGeAlD
Cladribine—Vidarabine—ADK—epilepsy syndrome	0.00147	0.187	CrCbGaD
Cladribine—RRM2B—nervous system—epilepsy syndrome	0.00146	0.0134	CbGeAlD
Cladribine—POLE3—head—epilepsy syndrome	0.00146	0.0133	CbGeAlD
Cladribine—NR5A1—head—epilepsy syndrome	0.00141	0.0129	CbGeAlD
Cladribine—RRM2B—central nervous system—epilepsy syndrome	0.00141	0.0129	CbGeAlD
Cladribine—POLE3—nervous system—epilepsy syndrome	0.00138	0.0126	CbGeAlD
Cladribine—RRM2B—cerebellum—epilepsy syndrome	0.00138	0.0126	CbGeAlD
Cladribine—NR5A1—nervous system—epilepsy syndrome	0.00134	0.0122	CbGeAlD
Cladribine—POLE3—central nervous system—epilepsy syndrome	0.00133	0.0122	CbGeAlD
Cladribine—RRM1—forebrain—epilepsy syndrome	0.00133	0.0121	CbGeAlD
Cladribine—POLE3—cerebellum—epilepsy syndrome	0.0013	0.0119	CbGeAlD
Cladribine—NR5A1—central nervous system—epilepsy syndrome	0.00129	0.0118	CbGeAlD
Cladribine—NR5A1—cerebellum—epilepsy syndrome	0.00126	0.0115	CbGeAlD
Cladribine—RRM1—telencephalon—epilepsy syndrome	0.00122	0.0112	CbGeAlD
Cladribine—PNP—brain—epilepsy syndrome	0.0012	0.011	CbGeAlD
Cladribine—Adenosine—ADK—epilepsy syndrome	0.00117	0.15	CrCbGaD
Cladribine—RRM2B—brain—epilepsy syndrome	0.00112	0.0102	CbGeAlD
Cladribine—POLE—head—epilepsy syndrome	0.00111	0.0102	CbGeAlD
Cladribine—POLE3—brain—epilepsy syndrome	0.00106	0.00965	CbGeAlD
Cladribine—POLE—nervous system—epilepsy syndrome	0.00105	0.00964	CbGeAlD
Cladribine—NR5A1—brain—epilepsy syndrome	0.00102	0.00936	CbGeAlD
Cladribine—POLE—central nervous system—epilepsy syndrome	0.00102	0.00928	CbGeAlD
Cladribine—POLE—cerebellum—epilepsy syndrome	0.000992	0.00907	CbGeAlD
Cladribine—RRM1—medulla oblongata—epilepsy syndrome	0.00096	0.00877	CbGeAlD
Cladribine—DCK—telencephalon—epilepsy syndrome	0.000949	0.00867	CbGeAlD
Cladribine—RRM2—head—epilepsy syndrome	0.000916	0.00837	CbGeAlD
Cladribine—SLC22A1—forebrain—epilepsy syndrome	0.00088	0.00804	CbGeAlD
Cladribine—RRM1—midbrain—epilepsy syndrome	0.000877	0.00802	CbGeAlD
Cladribine—RRM2—nervous system—epilepsy syndrome	0.000868	0.00794	CbGeAlD
Cladribine—RRM1—spinal cord—epilepsy syndrome	0.000856	0.00782	CbGeAlD
Cladribine—POLA1—cerebellum—epilepsy syndrome	0.000855	0.00782	CbGeAlD
Cladribine—Adenosine monophosphate—ADK—epilepsy syndrome	0.000849	0.108	CrCbGaD
Cladribine—POLE2—Alprazolam—Clonazepam—epilepsy syndrome	0.000841	0.171	CbGdCrCtD
Cladribine—RRM2—central nervous system—epilepsy syndrome	0.000836	0.00764	CbGeAlD
Cladribine—SLC22A1—telencephalon—epilepsy syndrome	0.000809	0.0074	CbGeAlD
Cladribine—POLE—brain—epilepsy syndrome	0.000806	0.00737	CbGeAlD
Cladribine—POLE2—Alprazolam—Midazolam—epilepsy syndrome	0.000803	0.163	CbGdCrCtD
Cladribine—POLE2—Alprazolam—Clobazam—epilepsy syndrome	0.000769	0.156	CbGdCrCtD
Cladribine—RRM1—head—epilepsy syndrome	0.000761	0.00695	CbGeAlD
Cladribine—DCK—medulla oblongata—epilepsy syndrome	0.000746	0.00681	CbGeAlD
Cladribine—RRM1—nervous system—epilepsy syndrome	0.000721	0.00659	CbGeAlD
Cladribine—POLE2—Alprazolam—Diazepam—epilepsy syndrome	0.000715	0.145	CbGdCrCtD
Cladribine—POLA1—brain—epilepsy syndrome	0.000695	0.00635	CbGeAlD
Cladribine—RRM1—central nervous system—epilepsy syndrome	0.000694	0.00635	CbGeAlD
Cladribine—DCK—midbrain—epilepsy syndrome	0.000682	0.00623	CbGeAlD
Cladribine—RRM1—cerebellum—epilepsy syndrome	0.000679	0.0062	CbGeAlD
Cladribine—DCK—spinal cord—epilepsy syndrome	0.000665	0.00608	CbGeAlD
Cladribine—RRM2—brain—epilepsy syndrome	0.000664	0.00607	CbGeAlD
Cladribine—POLE2—Niclosamide—Clonazepam—epilepsy syndrome	0.000595	0.121	CbGdCrCtD
Cladribine—DCK—head—epilepsy syndrome	0.000591	0.0054	CbGeAlD
Cladribine—DCK—nervous system—epilepsy syndrome	0.00056	0.00512	CbGeAlD
Cladribine—RRM1—brain—epilepsy syndrome	0.000551	0.00504	CbGeAlD
Cladribine—DCK—central nervous system—epilepsy syndrome	0.000539	0.00493	CbGeAlD
Cladribine—ABCG2—telencephalon—epilepsy syndrome	0.000529	0.00484	CbGeAlD
Cladribine—DCK—cerebellum—epilepsy syndrome	0.000527	0.00482	CbGeAlD
Cladribine—SLC22A1—head—epilepsy syndrome	0.000504	0.00461	CbGeAlD
Cladribine—SLC22A1—nervous system—epilepsy syndrome	0.000478	0.00437	CbGeAlD
Cladribine—RRM2—Niclosamide—Clonazepam—epilepsy syndrome	0.000472	0.096	CbGdCrCtD
Cladribine—SLC22A1—central nervous system—epilepsy syndrome	0.00046	0.0042	CbGeAlD
Cladribine—PNP—Niclosamide—Clonazepam—epilepsy syndrome	0.000459	0.0932	CbGdCrCtD
Cladribine—DCK—brain—epilepsy syndrome	0.000428	0.00391	CbGeAlD
Cladribine—ABCG2—medulla oblongata—epilepsy syndrome	0.000416	0.0038	CbGeAlD
Cladribine—ABCG2—midbrain—epilepsy syndrome	0.00038	0.00347	CbGeAlD
Cladribine—ABCG2—spinal cord—epilepsy syndrome	0.000371	0.00339	CbGeAlD
Cladribine—SLC22A1—brain—epilepsy syndrome	0.000365	0.00334	CbGeAlD
Cladribine—Adenosine monophosphate—SRC—epilepsy syndrome	0.000306	0.039	CrCbGaD
Cladribine—ABCG2—cerebellum—epilepsy syndrome	0.000294	0.00269	CbGeAlD
Cladribine—DCK—Niclosamide—Clonazepam—epilepsy syndrome	0.000268	0.0544	CbGdCrCtD
Cladribine—Clofarabine—ABCG2—epilepsy syndrome	0.000267	0.034	CrCbGaD
Cladribine—ABCG2—brain—epilepsy syndrome	0.000239	0.00218	CbGeAlD
Cladribine—Tachycardia—Valproic Acid—epilepsy syndrome	9.63e-05	0.000296	CcSEcCtD
Cladribine—Diarrhoea—Zonisamide—epilepsy syndrome	9.62e-05	0.000296	CcSEcCtD
Cladribine—Pharyngitis—Topiramate—epilepsy syndrome	9.61e-05	0.000296	CcSEcCtD
Cladribine—Asthenia—Oxcarbazepine—epilepsy syndrome	9.6e-05	0.000295	CcSEcCtD
Cladribine—Pruritus—Clonazepam—epilepsy syndrome	9.58e-05	0.000295	CcSEcCtD
Cladribine—Vomiting—Vigabatrin—epilepsy syndrome	9.58e-05	0.000295	CcSEcCtD
Cladribine—Skin disorder—Valproic Acid—epilepsy syndrome	9.58e-05	0.000295	CcSEcCtD
Cladribine—Urinary tract disorder—Topiramate—epilepsy syndrome	9.56e-05	0.000294	CcSEcCtD
Cladribine—Oedema peripheral—Topiramate—epilepsy syndrome	9.54e-05	0.000293	CcSEcCtD
Cladribine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	9.54e-05	0.000293	CcSEcCtD
Cladribine—Cough—Pregabalin—epilepsy syndrome	9.53e-05	0.000293	CcSEcCtD
Cladribine—Pruritus—Phenytoin—epilepsy syndrome	9.52e-05	0.000293	CcSEcCtD
Cladribine—Connective tissue disorder—Topiramate—epilepsy syndrome	9.52e-05	0.000293	CcSEcCtD
Cladribine—Nausea—Levetiracetam—epilepsy syndrome	9.51e-05	0.000293	CcSEcCtD
Cladribine—Rash—Vigabatrin—epilepsy syndrome	9.5e-05	0.000292	CcSEcCtD
Cladribine—Dizziness—Felbamate—epilepsy syndrome	9.5e-05	0.000292	CcSEcCtD
Cladribine—Dermatitis—Vigabatrin—epilepsy syndrome	9.49e-05	0.000292	CcSEcCtD
Cladribine—Urethral disorder—Topiramate—epilepsy syndrome	9.49e-05	0.000292	CcSEcCtD
Cladribine—Pruritus—Oxcarbazepine—epilepsy syndrome	9.47e-05	0.000291	CcSEcCtD
Cladribine—Hypersensitivity—Carbamazepine—epilepsy syndrome	9.46e-05	0.000291	CcSEcCtD
Cladribine—Headache—Vigabatrin—epilepsy syndrome	9.44e-05	0.00029	CcSEcCtD
Cladribine—Vomiting—Diazepam—epilepsy syndrome	9.43e-05	0.00029	CcSEcCtD
Cladribine—Anorexia—Valproic Acid—epilepsy syndrome	9.4e-05	0.000289	CcSEcCtD
Cladribine—Rash—Diazepam—epilepsy syndrome	9.35e-05	0.000288	CcSEcCtD
Cladribine—Dermatitis—Diazepam—epilepsy syndrome	9.35e-05	0.000287	CcSEcCtD
Cladribine—Chest pain—Pregabalin—epilepsy syndrome	9.3e-05	0.000286	CcSEcCtD
Cladribine—Myalgia—Pregabalin—epilepsy syndrome	9.3e-05	0.000286	CcSEcCtD
Cladribine—Arthralgia—Pregabalin—epilepsy syndrome	9.3e-05	0.000286	CcSEcCtD
Cladribine—Ill-defined disorder—Gabapentin—epilepsy syndrome	9.3e-05	0.000286	CcSEcCtD
Cladribine—Dizziness—Zonisamide—epilepsy syndrome	9.29e-05	0.000286	CcSEcCtD
Cladribine—Headache—Diazepam—epilepsy syndrome	9.29e-05	0.000286	CcSEcCtD
Cladribine—Anxiety—Pregabalin—epilepsy syndrome	9.27e-05	0.000285	CcSEcCtD
Cladribine—Diarrhoea—Clonazepam—epilepsy syndrome	9.27e-05	0.000285	CcSEcCtD
Cladribine—Anaemia—Gabapentin—epilepsy syndrome	9.26e-05	0.000285	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	9.24e-05	0.000284	CcSEcCtD
Cladribine—Hypotension—Valproic Acid—epilepsy syndrome	9.22e-05	0.000283	CcSEcCtD
Cladribine—Asthenia—Carbamazepine—epilepsy syndrome	9.22e-05	0.000283	CcSEcCtD
Cladribine—Diarrhoea—Phenytoin—epilepsy syndrome	9.21e-05	0.000283	CcSEcCtD
Cladribine—Discomfort—Pregabalin—epilepsy syndrome	9.19e-05	0.000283	CcSEcCtD
Cladribine—Nausea—Fosphenytoin—epilepsy syndrome	9.18e-05	0.000282	CcSEcCtD
Cladribine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	9.16e-05	0.000282	CcSEcCtD
Cladribine—Erythema multiforme—Topiramate—epilepsy syndrome	9.16e-05	0.000282	CcSEcCtD
Cladribine—Hypersensitivity—Lamotrigine—epilepsy syndrome	9.15e-05	0.000281	CcSEcCtD
Cladribine—Vomiting—Felbamate—epilepsy syndrome	9.13e-05	0.000281	CcSEcCtD
Cladribine—Pruritus—Carbamazepine—epilepsy syndrome	9.09e-05	0.000279	CcSEcCtD
Cladribine—Rash—Felbamate—epilepsy syndrome	9.05e-05	0.000278	CcSEcCtD
Cladribine—Eye disorder—Topiramate—epilepsy syndrome	9.05e-05	0.000278	CcSEcCtD
Cladribine—Dermatitis—Felbamate—epilepsy syndrome	9.05e-05	0.000278	CcSEcCtD
Cladribine—Malaise—Gabapentin—epilepsy syndrome	9.04e-05	0.000278	CcSEcCtD
Cladribine—Headache—Felbamate—epilepsy syndrome	9e-05	0.000277	CcSEcCtD
Cladribine—Confusional state—Pregabalin—epilepsy syndrome	8.99e-05	0.000276	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	8.99e-05	0.000276	CcSEcCtD
Cladribine—Cardiac disorder—Topiramate—epilepsy syndrome	8.99e-05	0.000276	CcSEcCtD
Cladribine—Dizziness—Clonazepam—epilepsy syndrome	8.96e-05	0.000275	CcSEcCtD
Cladribine—Nausea—Vigabatrin—epilepsy syndrome	8.95e-05	0.000275	CcSEcCtD
Cladribine—Vomiting—Zonisamide—epilepsy syndrome	8.94e-05	0.000275	CcSEcCtD
Cladribine—Insomnia—Valproic Acid—epilepsy syndrome	8.92e-05	0.000274	CcSEcCtD
Cladribine—Oedema—Pregabalin—epilepsy syndrome	8.92e-05	0.000274	CcSEcCtD
Cladribine—Asthenia—Lamotrigine—epilepsy syndrome	8.91e-05	0.000274	CcSEcCtD
Cladribine—Dizziness—Phenytoin—epilepsy syndrome	8.9e-05	0.000274	CcSEcCtD
Cladribine—Rash—Zonisamide—epilepsy syndrome	8.86e-05	0.000273	CcSEcCtD
Cladribine—Infection—Pregabalin—epilepsy syndrome	8.86e-05	0.000272	CcSEcCtD
Cladribine—Paraesthesia—Valproic Acid—epilepsy syndrome	8.86e-05	0.000272	CcSEcCtD
Cladribine—Dermatitis—Zonisamide—epilepsy syndrome	8.85e-05	0.000272	CcSEcCtD
Cladribine—Dizziness—Oxcarbazepine—epilepsy syndrome	8.85e-05	0.000272	CcSEcCtD
Cladribine—Nausea—Diazepam—epilepsy syndrome	8.81e-05	0.000271	CcSEcCtD
Cladribine—Headache—Zonisamide—epilepsy syndrome	8.81e-05	0.000271	CcSEcCtD
Cladribine—Dyspnoea—Valproic Acid—epilepsy syndrome	8.79e-05	0.00027	CcSEcCtD
Cladribine—Diarrhoea—Carbamazepine—epilepsy syndrome	8.79e-05	0.00027	CcSEcCtD
Cladribine—Angiopathy—Topiramate—epilepsy syndrome	8.79e-05	0.00027	CcSEcCtD
Cladribine—Pruritus—Lamotrigine—epilepsy syndrome	8.78e-05	0.00027	CcSEcCtD
Cladribine—Somnolence—Valproic Acid—epilepsy syndrome	8.77e-05	0.00027	CcSEcCtD
Cladribine—Immune system disorder—Topiramate—epilepsy syndrome	8.75e-05	0.000269	CcSEcCtD
Cladribine—Nervous system disorder—Pregabalin—epilepsy syndrome	8.75e-05	0.000269	CcSEcCtD
Cladribine—Cough—Gabapentin—epilepsy syndrome	8.74e-05	0.000269	CcSEcCtD
Cladribine—Thrombocytopenia—Pregabalin—epilepsy syndrome	8.73e-05	0.000268	CcSEcCtD
Cladribine—Mediastinal disorder—Topiramate—epilepsy syndrome	8.73e-05	0.000268	CcSEcCtD
Cladribine—Tachycardia—Pregabalin—epilepsy syndrome	8.7e-05	0.000268	CcSEcCtD
Cladribine—Chills—Topiramate—epilepsy syndrome	8.69e-05	0.000267	CcSEcCtD
Cladribine—Skin disorder—Pregabalin—epilepsy syndrome	8.66e-05	0.000266	CcSEcCtD
Cladribine—Hyperhidrosis—Pregabalin—epilepsy syndrome	8.62e-05	0.000265	CcSEcCtD
Cladribine—Vomiting—Clonazepam—epilepsy syndrome	8.61e-05	0.000265	CcSEcCtD
Cladribine—Decreased appetite—Valproic Acid—epilepsy syndrome	8.57e-05	0.000264	CcSEcCtD
Cladribine—Alopecia—Topiramate—epilepsy syndrome	8.56e-05	0.000263	CcSEcCtD
Cladribine—Vomiting—Phenytoin—epilepsy syndrome	8.56e-05	0.000263	CcSEcCtD
Cladribine—Rash—Clonazepam—epilepsy syndrome	8.54e-05	0.000263	CcSEcCtD
Cladribine—Dermatitis—Clonazepam—epilepsy syndrome	8.53e-05	0.000262	CcSEcCtD
Cladribine—Myalgia—Gabapentin—epilepsy syndrome	8.53e-05	0.000262	CcSEcCtD
Cladribine—Arthralgia—Gabapentin—epilepsy syndrome	8.53e-05	0.000262	CcSEcCtD
Cladribine—Chest pain—Gabapentin—epilepsy syndrome	8.53e-05	0.000262	CcSEcCtD
Cladribine—Nausea—Felbamate—epilepsy syndrome	8.53e-05	0.000262	CcSEcCtD
Cladribine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	8.52e-05	0.000262	CcSEcCtD
Cladribine—Vomiting—Oxcarbazepine—epilepsy syndrome	8.51e-05	0.000262	CcSEcCtD
Cladribine—Fatigue—Valproic Acid—epilepsy syndrome	8.5e-05	0.000262	CcSEcCtD
Cladribine—Anxiety—Gabapentin—epilepsy syndrome	8.5e-05	0.000261	CcSEcCtD
Cladribine—Anorexia—Pregabalin—epilepsy syndrome	8.5e-05	0.000261	CcSEcCtD
Cladribine—Dizziness—Carbamazepine—epilepsy syndrome	8.49e-05	0.000261	CcSEcCtD
Cladribine—Diarrhoea—Lamotrigine—epilepsy syndrome	8.49e-05	0.000261	CcSEcCtD
Cladribine—Headache—Clonazepam—epilepsy syndrome	8.49e-05	0.000261	CcSEcCtD
Cladribine—Rash—Phenytoin—epilepsy syndrome	8.48e-05	0.000261	CcSEcCtD
Cladribine—Mental disorder—Topiramate—epilepsy syndrome	8.48e-05	0.000261	CcSEcCtD
Cladribine—Dermatitis—Phenytoin—epilepsy syndrome	8.48e-05	0.000261	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	8.47e-05	0.00026	CcSEcCtD
Cladribine—Rash—Oxcarbazepine—epilepsy syndrome	8.44e-05	0.000259	CcSEcCtD
Cladribine—Pain—Valproic Acid—epilepsy syndrome	8.44e-05	0.000259	CcSEcCtD
Cladribine—Constipation—Valproic Acid—epilepsy syndrome	8.44e-05	0.000259	CcSEcCtD
Cladribine—Dermatitis—Oxcarbazepine—epilepsy syndrome	8.43e-05	0.000259	CcSEcCtD
Cladribine—Headache—Phenytoin—epilepsy syndrome	8.43e-05	0.000259	CcSEcCtD
Cladribine—Malnutrition—Topiramate—epilepsy syndrome	8.43e-05	0.000259	CcSEcCtD
Cladribine—Erythema—Topiramate—epilepsy syndrome	8.43e-05	0.000259	CcSEcCtD
Cladribine—Discomfort—Gabapentin—epilepsy syndrome	8.43e-05	0.000259	CcSEcCtD
Cladribine—Headache—Oxcarbazepine—epilepsy syndrome	8.38e-05	0.000258	CcSEcCtD
Cladribine—Nausea—Zonisamide—epilepsy syndrome	8.35e-05	0.000257	CcSEcCtD
Cladribine—Hypotension—Pregabalin—epilepsy syndrome	8.33e-05	0.000256	CcSEcCtD
Cladribine—Flatulence—Topiramate—epilepsy syndrome	8.31e-05	0.000255	CcSEcCtD
Cladribine—Confusional state—Gabapentin—epilepsy syndrome	8.25e-05	0.000254	CcSEcCtD
Cladribine—Dizziness—Lamotrigine—epilepsy syndrome	8.21e-05	0.000252	CcSEcCtD
Cladribine—Oedema—Gabapentin—epilepsy syndrome	8.18e-05	0.000251	CcSEcCtD
Cladribine—Vomiting—Carbamazepine—epilepsy syndrome	8.17e-05	0.000251	CcSEcCtD
Cladribine—Back pain—Topiramate—epilepsy syndrome	8.15e-05	0.000251	CcSEcCtD
Cladribine—Feeling abnormal—Valproic Acid—epilepsy syndrome	8.13e-05	0.00025	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	8.12e-05	0.00025	CcSEcCtD
Cladribine—Infection—Gabapentin—epilepsy syndrome	8.12e-05	0.00025	CcSEcCtD
Cladribine—Rash—Carbamazepine—epilepsy syndrome	8.1e-05	0.000249	CcSEcCtD
Cladribine—Dermatitis—Carbamazepine—epilepsy syndrome	8.09e-05	0.000249	CcSEcCtD
Cladribine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	8.07e-05	0.000248	CcSEcCtD
Cladribine—Insomnia—Pregabalin—epilepsy syndrome	8.07e-05	0.000248	CcSEcCtD
Cladribine—Nausea—Clonazepam—epilepsy syndrome	8.05e-05	0.000247	CcSEcCtD
Cladribine—Headache—Carbamazepine—epilepsy syndrome	8.05e-05	0.000247	CcSEcCtD
Cladribine—Nervous system disorder—Gabapentin—epilepsy syndrome	8.02e-05	0.000247	CcSEcCtD
Cladribine—Paraesthesia—Pregabalin—epilepsy syndrome	8.01e-05	0.000246	CcSEcCtD
Cladribine—Thrombocytopenia—Gabapentin—epilepsy syndrome	8.01e-05	0.000246	CcSEcCtD
Cladribine—Nausea—Phenytoin—epilepsy syndrome	7.99e-05	0.000246	CcSEcCtD
Cladribine—Tachycardia—Gabapentin—epilepsy syndrome	7.98e-05	0.000245	CcSEcCtD
Cladribine—Dyspnoea—Pregabalin—epilepsy syndrome	7.95e-05	0.000244	CcSEcCtD
Cladribine—Nausea—Oxcarbazepine—epilepsy syndrome	7.95e-05	0.000244	CcSEcCtD
Cladribine—Skin disorder—Gabapentin—epilepsy syndrome	7.94e-05	0.000244	CcSEcCtD
Cladribine—Somnolence—Pregabalin—epilepsy syndrome	7.93e-05	0.000244	CcSEcCtD
Cladribine—Hyperhidrosis—Gabapentin—epilepsy syndrome	7.91e-05	0.000243	CcSEcCtD
Cladribine—Vomiting—Lamotrigine—epilepsy syndrome	7.89e-05	0.000243	CcSEcCtD
Cladribine—Urticaria—Valproic Acid—epilepsy syndrome	7.84e-05	0.000241	CcSEcCtD
Cladribine—Rash—Lamotrigine—epilepsy syndrome	7.83e-05	0.000241	CcSEcCtD
Cladribine—Ill-defined disorder—Topiramate—epilepsy syndrome	7.82e-05	0.00024	CcSEcCtD
Cladribine—Dermatitis—Lamotrigine—epilepsy syndrome	7.82e-05	0.00024	CcSEcCtD
Cladribine—Body temperature increased—Valproic Acid—epilepsy syndrome	7.8e-05	0.00024	CcSEcCtD
Cladribine—Abdominal pain—Valproic Acid—epilepsy syndrome	7.8e-05	0.00024	CcSEcCtD
Cladribine—Anorexia—Gabapentin—epilepsy syndrome	7.79e-05	0.00024	CcSEcCtD
Cladribine—Anaemia—Topiramate—epilepsy syndrome	7.79e-05	0.00024	CcSEcCtD
Cladribine—Headache—Lamotrigine—epilepsy syndrome	7.78e-05	0.000239	CcSEcCtD
Cladribine—Decreased appetite—Pregabalin—epilepsy syndrome	7.75e-05	0.000238	CcSEcCtD
Cladribine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	7.7e-05	0.000237	CcSEcCtD
Cladribine—Fatigue—Pregabalin—epilepsy syndrome	7.69e-05	0.000236	CcSEcCtD
Cladribine—Hypotension—Gabapentin—epilepsy syndrome	7.64e-05	0.000235	CcSEcCtD
Cladribine—Nausea—Carbamazepine—epilepsy syndrome	7.63e-05	0.000235	CcSEcCtD
Cladribine—Pain—Pregabalin—epilepsy syndrome	7.63e-05	0.000234	CcSEcCtD
Cladribine—Constipation—Pregabalin—epilepsy syndrome	7.63e-05	0.000234	CcSEcCtD
Cladribine—Malaise—Topiramate—epilepsy syndrome	7.6e-05	0.000234	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	7.45e-05	0.000229	CcSEcCtD
Cladribine—Insomnia—Gabapentin—epilepsy syndrome	7.4e-05	0.000227	CcSEcCtD
Cladribine—Nausea—Lamotrigine—epilepsy syndrome	7.37e-05	0.000227	CcSEcCtD
Cladribine—Cough—Topiramate—epilepsy syndrome	7.36e-05	0.000226	CcSEcCtD
Cladribine—Feeling abnormal—Pregabalin—epilepsy syndrome	7.35e-05	0.000226	CcSEcCtD
Cladribine—Paraesthesia—Gabapentin—epilepsy syndrome	7.34e-05	0.000226	CcSEcCtD
Cladribine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	7.29e-05	0.000224	CcSEcCtD
Cladribine—Dyspnoea—Gabapentin—epilepsy syndrome	7.29e-05	0.000224	CcSEcCtD
Cladribine—Somnolence—Gabapentin—epilepsy syndrome	7.27e-05	0.000224	CcSEcCtD
Cladribine—Hypersensitivity—Valproic Acid—epilepsy syndrome	7.27e-05	0.000223	CcSEcCtD
Cladribine—Chest pain—Topiramate—epilepsy syndrome	7.18e-05	0.000221	CcSEcCtD
Cladribine—Myalgia—Topiramate—epilepsy syndrome	7.18e-05	0.000221	CcSEcCtD
Cladribine—Arthralgia—Topiramate—epilepsy syndrome	7.18e-05	0.000221	CcSEcCtD
Cladribine—Anxiety—Topiramate—epilepsy syndrome	7.15e-05	0.00022	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	7.13e-05	0.000219	CcSEcCtD
Cladribine—Decreased appetite—Gabapentin—epilepsy syndrome	7.11e-05	0.000219	CcSEcCtD
Cladribine—Discomfort—Topiramate—epilepsy syndrome	7.09e-05	0.000218	CcSEcCtD
Cladribine—Urticaria—Pregabalin—epilepsy syndrome	7.08e-05	0.000218	CcSEcCtD
Cladribine—Asthenia—Valproic Acid—epilepsy syndrome	7.08e-05	0.000218	CcSEcCtD
Cladribine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	7.06e-05	0.000217	CcSEcCtD
Cladribine—Fatigue—Gabapentin—epilepsy syndrome	7.05e-05	0.000217	CcSEcCtD
Cladribine—Abdominal pain—Pregabalin—epilepsy syndrome	7.05e-05	0.000217	CcSEcCtD
Cladribine—Body temperature increased—Pregabalin—epilepsy syndrome	7.05e-05	0.000217	CcSEcCtD
Cladribine—Pain—Gabapentin—epilepsy syndrome	6.99e-05	0.000215	CcSEcCtD
Cladribine—Constipation—Gabapentin—epilepsy syndrome	6.99e-05	0.000215	CcSEcCtD
Cladribine—Pruritus—Valproic Acid—epilepsy syndrome	6.98e-05	0.000215	CcSEcCtD
Cladribine—Confusional state—Topiramate—epilepsy syndrome	6.94e-05	0.000213	CcSEcCtD
Cladribine—Oedema—Topiramate—epilepsy syndrome	6.88e-05	0.000212	CcSEcCtD
Cladribine—Infection—Topiramate—epilepsy syndrome	6.83e-05	0.00021	CcSEcCtD
Cladribine—Diarrhoea—Valproic Acid—epilepsy syndrome	6.75e-05	0.000208	CcSEcCtD
Cladribine—Nervous system disorder—Topiramate—epilepsy syndrome	6.75e-05	0.000207	CcSEcCtD
Cladribine—Feeling abnormal—Gabapentin—epilepsy syndrome	6.74e-05	0.000207	CcSEcCtD
Cladribine—Thrombocytopenia—Topiramate—epilepsy syndrome	6.74e-05	0.000207	CcSEcCtD
Cladribine—Tachycardia—Topiramate—epilepsy syndrome	6.71e-05	0.000206	CcSEcCtD
Cladribine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	6.69e-05	0.000206	CcSEcCtD
Cladribine—Skin disorder—Topiramate—epilepsy syndrome	6.68e-05	0.000205	CcSEcCtD
Cladribine—Hyperhidrosis—Topiramate—epilepsy syndrome	6.65e-05	0.000205	CcSEcCtD
Cladribine—Hypersensitivity—Pregabalin—epilepsy syndrome	6.57e-05	0.000202	CcSEcCtD
Cladribine—Anorexia—Topiramate—epilepsy syndrome	6.56e-05	0.000202	CcSEcCtD
Cladribine—Dizziness—Valproic Acid—epilepsy syndrome	6.52e-05	0.000201	CcSEcCtD
Cladribine—Urticaria—Gabapentin—epilepsy syndrome	6.5e-05	0.0002	CcSEcCtD
Cladribine—Abdominal pain—Gabapentin—epilepsy syndrome	6.46e-05	0.000199	CcSEcCtD
Cladribine—Body temperature increased—Gabapentin—epilepsy syndrome	6.46e-05	0.000199	CcSEcCtD
Cladribine—Hypotension—Topiramate—epilepsy syndrome	6.43e-05	0.000198	CcSEcCtD
Cladribine—Asthenia—Pregabalin—epilepsy syndrome	6.4e-05	0.000197	CcSEcCtD
Cladribine—Pruritus—Pregabalin—epilepsy syndrome	6.31e-05	0.000194	CcSEcCtD
Cladribine—Vomiting—Valproic Acid—epilepsy syndrome	6.27e-05	0.000193	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	6.27e-05	0.000193	CcSEcCtD
Cladribine—Insomnia—Topiramate—epilepsy syndrome	6.22e-05	0.000191	CcSEcCtD
Cladribine—Rash—Valproic Acid—epilepsy syndrome	6.22e-05	0.000191	CcSEcCtD
Cladribine—Dermatitis—Valproic Acid—epilepsy syndrome	6.21e-05	0.000191	CcSEcCtD
Cladribine—Headache—Valproic Acid—epilepsy syndrome	6.18e-05	0.00019	CcSEcCtD
Cladribine—Paraesthesia—Topiramate—epilepsy syndrome	6.18e-05	0.00019	CcSEcCtD
Cladribine—Dyspnoea—Topiramate—epilepsy syndrome	6.13e-05	0.000189	CcSEcCtD
Cladribine—Somnolence—Topiramate—epilepsy syndrome	6.12e-05	0.000188	CcSEcCtD
Cladribine—Diarrhoea—Pregabalin—epilepsy syndrome	6.1e-05	0.000188	CcSEcCtD
Cladribine—Hypersensitivity—Gabapentin—epilepsy syndrome	6.02e-05	0.000185	CcSEcCtD
Cladribine—Decreased appetite—Topiramate—epilepsy syndrome	5.98e-05	0.000184	CcSEcCtD
Cladribine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	5.94e-05	0.000183	CcSEcCtD
Cladribine—Fatigue—Topiramate—epilepsy syndrome	5.93e-05	0.000182	CcSEcCtD
Cladribine—Dizziness—Pregabalin—epilepsy syndrome	5.9e-05	0.000181	CcSEcCtD
Cladribine—Pain—Topiramate—epilepsy syndrome	5.88e-05	0.000181	CcSEcCtD
Cladribine—Constipation—Topiramate—epilepsy syndrome	5.88e-05	0.000181	CcSEcCtD
Cladribine—Asthenia—Gabapentin—epilepsy syndrome	5.87e-05	0.00018	CcSEcCtD
Cladribine—Nausea—Valproic Acid—epilepsy syndrome	5.86e-05	0.00018	CcSEcCtD
Cladribine—Pruritus—Gabapentin—epilepsy syndrome	5.79e-05	0.000178	CcSEcCtD
Cladribine—Vomiting—Pregabalin—epilepsy syndrome	5.67e-05	0.000174	CcSEcCtD
Cladribine—Feeling abnormal—Topiramate—epilepsy syndrome	5.67e-05	0.000174	CcSEcCtD
Cladribine—Gastrointestinal pain—Topiramate—epilepsy syndrome	5.63e-05	0.000173	CcSEcCtD
Cladribine—Rash—Pregabalin—epilepsy syndrome	5.62e-05	0.000173	CcSEcCtD
Cladribine—Dermatitis—Pregabalin—epilepsy syndrome	5.62e-05	0.000173	CcSEcCtD
Cladribine—Diarrhoea—Gabapentin—epilepsy syndrome	5.59e-05	0.000172	CcSEcCtD
Cladribine—Headache—Pregabalin—epilepsy syndrome	5.59e-05	0.000172	CcSEcCtD
Cladribine—Urticaria—Topiramate—epilepsy syndrome	5.47e-05	0.000168	CcSEcCtD
Cladribine—Body temperature increased—Topiramate—epilepsy syndrome	5.44e-05	0.000167	CcSEcCtD
Cladribine—Abdominal pain—Topiramate—epilepsy syndrome	5.44e-05	0.000167	CcSEcCtD
Cladribine—Dizziness—Gabapentin—epilepsy syndrome	5.41e-05	0.000166	CcSEcCtD
Cladribine—Nausea—Pregabalin—epilepsy syndrome	5.3e-05	0.000163	CcSEcCtD
Cladribine—Vomiting—Gabapentin—epilepsy syndrome	5.2e-05	0.00016	CcSEcCtD
Cladribine—Rash—Gabapentin—epilepsy syndrome	5.16e-05	0.000159	CcSEcCtD
Cladribine—Dermatitis—Gabapentin—epilepsy syndrome	5.15e-05	0.000158	CcSEcCtD
Cladribine—Headache—Gabapentin—epilepsy syndrome	5.12e-05	0.000158	CcSEcCtD
Cladribine—Hypersensitivity—Topiramate—epilepsy syndrome	5.07e-05	0.000156	CcSEcCtD
Cladribine—Asthenia—Topiramate—epilepsy syndrome	4.94e-05	0.000152	CcSEcCtD
Cladribine—Pruritus—Topiramate—epilepsy syndrome	4.87e-05	0.00015	CcSEcCtD
Cladribine—Nausea—Gabapentin—epilepsy syndrome	4.86e-05	0.000149	CcSEcCtD
Cladribine—Diarrhoea—Topiramate—epilepsy syndrome	4.71e-05	0.000145	CcSEcCtD
Cladribine—Dizziness—Topiramate—epilepsy syndrome	4.55e-05	0.00014	CcSEcCtD
Cladribine—Vomiting—Topiramate—epilepsy syndrome	4.37e-05	0.000135	CcSEcCtD
Cladribine—Rash—Topiramate—epilepsy syndrome	4.34e-05	0.000133	CcSEcCtD
Cladribine—Dermatitis—Topiramate—epilepsy syndrome	4.33e-05	0.000133	CcSEcCtD
Cladribine—Headache—Topiramate—epilepsy syndrome	4.31e-05	0.000133	CcSEcCtD
Cladribine—Nausea—Topiramate—epilepsy syndrome	4.09e-05	0.000126	CcSEcCtD
Cladribine—SLC22A2—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	2.45e-05	0.000111	CbGpPWpGaD
Cladribine—RRM2—Metabolism—CYP11A1—epilepsy syndrome	2.44e-05	0.000111	CbGpPWpGaD
Cladribine—RRM1—Metabolism—SLC2A1—epilepsy syndrome	2.42e-05	0.00011	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—ALB—epilepsy syndrome	2.4e-05	0.000109	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PLCB1—epilepsy syndrome	2.4e-05	0.000109	CbGpPWpGaD
Cladribine—RRM1—Metabolism—TH—epilepsy syndrome	2.39e-05	0.000108	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—H2AFX—epilepsy syndrome	2.37e-05	0.000108	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CA4—epilepsy syndrome	2.37e-05	0.000108	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—QDPR—epilepsy syndrome	2.37e-05	0.000108	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	2.37e-05	0.000108	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	2.36e-05	0.000107	CbGpPWpGaD
Cladribine—DCK—Metabolism—ABCG2—epilepsy syndrome	2.36e-05	0.000107	CbGpPWpGaD
Cladribine—SLC22A1—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	2.36e-05	0.000107	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—NHLRC1—epilepsy syndrome	2.35e-05	0.000107	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PNPO—epilepsy syndrome	2.35e-05	0.000107	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GAMT—epilepsy syndrome	2.35e-05	0.000107	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—EPM2A—epilepsy syndrome	2.35e-05	0.000107	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—QDPR—epilepsy syndrome	2.35e-05	0.000106	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CA4—epilepsy syndrome	2.35e-05	0.000106	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	2.35e-05	0.000106	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—TNF—epilepsy syndrome	2.3e-05	0.000104	CbGpPWpGaD
Cladribine—DCK—Metabolism—CYP2C19—epilepsy syndrome	2.3e-05	0.000104	CbGpPWpGaD
Cladribine—PNP—Metabolism—POMC—epilepsy syndrome	2.29e-05	0.000104	CbGpPWpGaD
Cladribine—DCK—Metabolism—CYP11A1—epilepsy syndrome	2.28e-05	0.000104	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	2.28e-05	0.000103	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	2.28e-05	0.000103	CbGpPWpGaD
Cladribine—SLC22A2—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	2.28e-05	0.000103	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—COX3—epilepsy syndrome	2.23e-05	0.000101	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—COX3—epilepsy syndrome	2.21e-05	0.0001	CbGpPWpGaD
Cladribine—RRM2—Metabolism—CYP2D6—epilepsy syndrome	2.21e-05	0.0001	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	2.2e-05	0.0001	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CA4—epilepsy syndrome	2.19e-05	9.92e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—QDPR—epilepsy syndrome	2.19e-05	9.92e-05	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	2.19e-05	9.92e-05	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	2.18e-05	9.89e-05	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	2.14e-05	9.71e-05	CbGpPWpGaD
Cladribine—SLC22A1—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	2.12e-05	9.62e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—KCNB1—epilepsy syndrome	2.11e-05	9.59e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PFKL—epilepsy syndrome	2.11e-05	9.59e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—SLCO1A2—epilepsy syndrome	2.11e-05	9.59e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CACNA2D2—epilepsy syndrome	2.11e-05	9.59e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—SLC6A8—epilepsy syndrome	2.11e-05	9.59e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—PRKCB—epilepsy syndrome	2.11e-05	9.58e-05	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—PTGS2—epilepsy syndrome	2.1e-05	9.54e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—ADRA2A—epilepsy syndrome	2.1e-05	9.53e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—KCNB1—epilepsy syndrome	2.09e-05	9.49e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PFKL—epilepsy syndrome	2.09e-05	9.49e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—BCHE—epilepsy syndrome	2.09e-05	9.49e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CACNA2D2—epilepsy syndrome	2.09e-05	9.49e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—SLCO1A2—epilepsy syndrome	2.09e-05	9.49e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—SLC6A8—epilepsy syndrome	2.09e-05	9.49e-05	CbGpPWpGaD
Cladribine—PNP—Metabolism—ALB—epilepsy syndrome	2.08e-05	9.45e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—CYP2D6—epilepsy syndrome	2.06e-05	9.35e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—COX3—epilepsy syndrome	2.06e-05	9.33e-05	CbGpPWpGaD
Cladribine—ABCG2—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	2.04e-05	9.25e-05	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	2.03e-05	9.22e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—SLC2A1—epilepsy syndrome	2e-05	9.05e-05	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	1.99e-05	9.05e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—HMOX1—epilepsy syndrome	1.99e-05	9.04e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PLCB1—epilepsy syndrome	1.97e-05	8.95e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—TH—epilepsy syndrome	1.97e-05	8.92e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—CAT—epilepsy syndrome	1.97e-05	8.92e-05	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	1.96e-05	8.91e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—ADRA2A—epilepsy syndrome	1.96e-05	8.9e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—BCHE—epilepsy syndrome	1.95e-05	8.87e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CACNA2D2—epilepsy syndrome	1.95e-05	8.84e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PFKL—epilepsy syndrome	1.95e-05	8.84e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—SLCO1A2—epilepsy syndrome	1.95e-05	8.84e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—SLC6A8—epilepsy syndrome	1.95e-05	8.84e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—KCNB1—epilepsy syndrome	1.95e-05	8.84e-05	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	1.94e-05	8.82e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—NEU1—epilepsy syndrome	1.93e-05	8.77e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—UPB1—epilepsy syndrome	1.93e-05	8.77e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ATIC—epilepsy syndrome	1.93e-05	8.77e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—ATM—epilepsy syndrome	1.93e-05	8.75e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ATIC—epilepsy syndrome	1.91e-05	8.68e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—UPB1—epilepsy syndrome	1.91e-05	8.68e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—ABCB1—epilepsy syndrome	1.91e-05	8.68e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—NEU1—epilepsy syndrome	1.91e-05	8.68e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—PRKCB—epilepsy syndrome	1.89e-05	8.57e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—SLC2A1—epilepsy syndrome	1.86e-05	8.46e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—HSD17B4—epilepsy syndrome	1.86e-05	8.44e-05	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	1.86e-05	8.43e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—PLCB1—epilepsy syndrome	1.84e-05	8.37e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—HSD17B4—epilepsy syndrome	1.84e-05	8.35e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—TH—epilepsy syndrome	1.84e-05	8.34e-05	CbGpPWpGaD
Cladribine—PNP—Metabolism—PTGS2—epilepsy syndrome	1.82e-05	8.27e-05	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	1.81e-05	8.22e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GBE1—epilepsy syndrome	1.8e-05	8.15e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PPP1R3C—epilepsy syndrome	1.8e-05	8.15e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—UPB1—epilepsy syndrome	1.78e-05	8.09e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ATIC—epilepsy syndrome	1.78e-05	8.09e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—NEU1—epilepsy syndrome	1.78e-05	8.09e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PPP1R3C—epilepsy syndrome	1.78e-05	8.07e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GBE1—epilepsy syndrome	1.78e-05	8.07e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—GPX1—epilepsy syndrome	1.78e-05	8.07e-05	CbGpPWpGaD
Cladribine—SLC22A2—Neuronal System—PRKCB—epilepsy syndrome	1.74e-05	7.91e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—HSD17B4—epilepsy syndrome	1.72e-05	7.79e-05	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—AKT1—epilepsy syndrome	1.71e-05	7.77e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ASAH1—epilepsy syndrome	1.69e-05	7.66e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ASAH1—epilepsy syndrome	1.67e-05	7.58e-05	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.67e-05	7.58e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GBE1—epilepsy syndrome	1.66e-05	7.52e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PPP1R3C—epilepsy syndrome	1.66e-05	7.52e-05	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.65e-05	7.5e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—STXBP1—epilepsy syndrome	1.64e-05	7.46e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—HMOX1—epilepsy syndrome	1.64e-05	7.45e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—STXBP1—epilepsy syndrome	1.63e-05	7.38e-05	CbGpPWpGaD
Cladribine—SLC22A1—Neuronal System—PRKCB—epilepsy syndrome	1.63e-05	7.37e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—CAT—epilepsy syndrome	1.62e-05	7.35e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—NT5E—epilepsy syndrome	1.6e-05	7.27e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ALAD—epilepsy syndrome	1.6e-05	7.27e-05	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.59e-05	7.23e-05	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.59e-05	7.23e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ALAD—epilepsy syndrome	1.59e-05	7.19e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—NT5E—epilepsy syndrome	1.59e-05	7.19e-05	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.58e-05	7.15e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—ABCB1—epilepsy syndrome	1.58e-05	7.15e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—AGT—epilepsy syndrome	1.56e-05	7.07e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ASAH1—epilepsy syndrome	1.56e-05	7.07e-05	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.54e-05	6.99e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—HMOX1—epilepsy syndrome	1.53e-05	6.96e-05	CbGpPWpGaD
Cladribine—SLC22A2—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	1.53e-05	6.95e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CACNA1A—epilepsy syndrome	1.53e-05	6.93e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—APOE—epilepsy syndrome	1.53e-05	6.93e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ALDH7A1—epilepsy syndrome	1.53e-05	6.93e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—STXBP1—epilepsy syndrome	1.52e-05	6.88e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—CAT—epilepsy syndrome	1.51e-05	6.86e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CACNA1A—epilepsy syndrome	1.51e-05	6.86e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ALDH7A1—epilepsy syndrome	1.51e-05	6.86e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ST3GAL3—epilepsy syndrome	1.5e-05	6.78e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ST3GAL3—epilepsy syndrome	1.48e-05	6.71e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—NT5E—epilepsy syndrome	1.48e-05	6.7e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ALAD—epilepsy syndrome	1.48e-05	6.7e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—ABCB1—epilepsy syndrome	1.47e-05	6.68e-05	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.47e-05	6.67e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ADSL—epilepsy syndrome	1.46e-05	6.65e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—GPX1—epilepsy syndrome	1.46e-05	6.64e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ADSL—epilepsy syndrome	1.45e-05	6.58e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GLUL—epilepsy syndrome	1.44e-05	6.52e-05	CbGpPWpGaD
Cladribine—SLC22A1—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	1.43e-05	6.48e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GLUL—epilepsy syndrome	1.42e-05	6.45e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CACNA1D—epilepsy syndrome	1.41e-05	6.4e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CACNA1A—epilepsy syndrome	1.41e-05	6.39e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ALDH7A1—epilepsy syndrome	1.41e-05	6.39e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CACNA1D—epilepsy syndrome	1.4e-05	6.33e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ST3GAL3—epilepsy syndrome	1.38e-05	6.26e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—GPX1—epilepsy syndrome	1.37e-05	6.21e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ADSL—epilepsy syndrome	1.35e-05	6.13e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GLUL—epilepsy syndrome	1.33e-05	6.01e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—TXNRD1—epilepsy syndrome	1.32e-05	5.98e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—POMC—epilepsy syndrome	1.31e-05	5.95e-05	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.31e-05	5.94e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—TXNRD1—epilepsy syndrome	1.31e-05	5.92e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CACNA1D—epilepsy syndrome	1.3e-05	5.9e-05	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.3e-05	5.89e-05	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.3e-05	5.88e-05	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.29e-05	5.83e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—AGT—epilepsy syndrome	1.28e-05	5.83e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—AQP1—epilepsy syndrome	1.28e-05	5.81e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—AQP1—epilepsy syndrome	1.27e-05	5.75e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—APOE—epilepsy syndrome	1.26e-05	5.71e-05	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.26e-05	5.71e-05	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.24e-05	5.65e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—TXNRD1—epilepsy syndrome	1.22e-05	5.52e-05	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.21e-05	5.48e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—AGT—epilepsy syndrome	1.2e-05	5.44e-05	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.2e-05	5.43e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—ALB—epilepsy syndrome	1.2e-05	5.43e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—AQP1—epilepsy syndrome	1.18e-05	5.36e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—APOE—epilepsy syndrome	1.18e-05	5.33e-05	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.16e-05	5.26e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—KCNJ11—epilepsy syndrome	1.16e-05	5.25e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CHRM3—epilepsy syndrome	1.16e-05	5.25e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—KCNJ11—epilepsy syndrome	1.15e-05	5.2e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CHRM3—epilepsy syndrome	1.15e-05	5.2e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—POMC—epilepsy syndrome	1.08e-05	4.9e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CHRM3—epilepsy syndrome	1.07e-05	4.85e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—KCNJ11—epilepsy syndrome	1.07e-05	4.85e-05	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—AKT1—epilepsy syndrome	1.06e-05	4.79e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PTGS2—epilepsy syndrome	1.05e-05	4.75e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—POMC—epilepsy syndrome	1.01e-05	4.58e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—ALB—epilepsy syndrome	9.85e-06	4.47e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ABCG2—epilepsy syndrome	9.34e-06	4.24e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—ALB—epilepsy syndrome	9.21e-06	4.18e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP2C19—epilepsy syndrome	9.2e-06	4.17e-05	CbGpPWpGaD
Cladribine—PNP—Metabolism—AKT1—epilepsy syndrome	9.16e-06	4.16e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP11A1—epilepsy syndrome	9.14e-06	4.15e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP2C19—epilepsy syndrome	9.1e-06	4.13e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP11A1—epilepsy syndrome	9.05e-06	4.1e-05	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—AKT1—epilepsy syndrome	8.76e-06	3.97e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ABCG2—epilepsy syndrome	8.71e-06	3.95e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PTGS2—epilepsy syndrome	8.62e-06	3.91e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP2C19—epilepsy syndrome	8.49e-06	3.85e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP11A1—epilepsy syndrome	8.43e-06	3.83e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP2D6—epilepsy syndrome	8.25e-06	3.74e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP2D6—epilepsy syndrome	8.17e-06	3.7e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—PTGS2—epilepsy syndrome	8.06e-06	3.65e-05	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	7.87e-06	3.57e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ADRA2A—epilepsy syndrome	7.85e-06	3.56e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—BCHE—epilepsy syndrome	7.82e-06	3.55e-05	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	7.79e-06	3.53e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ADRA2A—epilepsy syndrome	7.77e-06	3.53e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—BCHE—epilepsy syndrome	7.74e-06	3.51e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP2D6—epilepsy syndrome	7.61e-06	3.45e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—SLC2A1—epilepsy syndrome	7.46e-06	3.38e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—SLC2A1—epilepsy syndrome	7.38e-06	3.35e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PLCB1—epilepsy syndrome	7.38e-06	3.35e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—TH—epilepsy syndrome	7.35e-06	3.34e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PLCB1—epilepsy syndrome	7.3e-06	3.31e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—TH—epilepsy syndrome	7.28e-06	3.3e-05	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	7.26e-06	3.29e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ADRA2A—epilepsy syndrome	7.25e-06	3.29e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—BCHE—epilepsy syndrome	7.22e-06	3.27e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—SLC2A1—epilepsy syndrome	6.88e-06	3.12e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PLCB1—epilepsy syndrome	6.81e-06	3.09e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—TH—epilepsy syndrome	6.78e-06	3.08e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—HMOX1—epilepsy syndrome	6.14e-06	2.78e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—HMOX1—epilepsy syndrome	6.07e-06	2.76e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CAT—epilepsy syndrome	6.06e-06	2.75e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CAT—epilepsy syndrome	5.99e-06	2.72e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ABCB1—epilepsy syndrome	5.89e-06	2.67e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ABCB1—epilepsy syndrome	5.83e-06	2.64e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—HMOX1—epilepsy syndrome	5.66e-06	2.57e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CAT—epilepsy syndrome	5.59e-06	2.53e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GPX1—epilepsy syndrome	5.48e-06	2.48e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ABCB1—epilepsy syndrome	5.43e-06	2.47e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GPX1—epilepsy syndrome	5.42e-06	2.46e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—AKT1—epilepsy syndrome	5.26e-06	2.39e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GPX1—epilepsy syndrome	5.05e-06	2.29e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—AGT—epilepsy syndrome	4.8e-06	2.18e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—AGT—epilepsy syndrome	4.75e-06	2.16e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—APOE—epilepsy syndrome	4.71e-06	2.13e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—APOE—epilepsy syndrome	4.66e-06	2.11e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—AGT—epilepsy syndrome	4.43e-06	2.01e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—APOE—epilepsy syndrome	4.34e-06	1.97e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—AKT1—epilepsy syndrome	4.33e-06	1.97e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—AKT1—epilepsy syndrome	4.05e-06	1.84e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—POMC—epilepsy syndrome	4.04e-06	1.83e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—POMC—epilepsy syndrome	4e-06	1.81e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—POMC—epilepsy syndrome	3.73e-06	1.69e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ALB—epilepsy syndrome	3.69e-06	1.67e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ALB—epilepsy syndrome	3.65e-06	1.65e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ALB—epilepsy syndrome	3.4e-06	1.54e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PTGS2—epilepsy syndrome	3.22e-06	1.46e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PTGS2—epilepsy syndrome	3.19e-06	1.45e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PTGS2—epilepsy syndrome	2.97e-06	1.35e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—AKT1—epilepsy syndrome	1.62e-06	7.35e-06	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—AKT1—epilepsy syndrome	1.6e-06	7.27e-06	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—AKT1—epilepsy syndrome	1.49e-06	6.78e-06	CbGpPWpGaD
